The global Mirtazapine Drug Market size was valued at USD 1.6 Billion in 2022 and is expected to grow at a CAGR of 6% during 2022 to 2030 to reach USD 2.8 Billion by 2030.

Mirtazapine Drug Market Overview:

Mirtazapine drug market is a tetracyclic antidepressant (TCA) used as an adjunct drug in the treatment of major depressive disorder, anxiety disorders, and panic disorders. It also helps relieve symptoms of dysthymia, premenstrual restlessness, and loss of appetite. Mirtazapine was developed by Organon International Inc., which is now part of AkzoNobel N.V., and has been discontinued from the market due to patent expiration.

Mirtazapine is an antidepressant that belongs to the class of serotonin-norepinephrine reuptake inhibitors. It contains both SSRI and SNRI properties, so it can be used as an alternative therapy for people who do not respond well to SSRI-only antidepressants. This medication is used to treat various conditions such as depression, anxiety, and chronic pain. It can also be used for other purposes, such as eating disorders and bipolar disorder. Mirtazapine was approved by the FDA in 1996. It is only available by prescription and should be taken under medical supervision. Some of its side effects include drowsiness, weight gain, dry mouth, constipation, and increased appetite.

Mirtazapine Drug market size estimates and forecasts are provided in terms of sales volume (K units) and revenue (million USD), with historical and forecast data for the period 2017 to 2030, with 2022 being considered as the base year. This report segments the global Mirtazapine Drug market in detail. Regional market sizes related to products by type, by application, and by player are also delivered. In estimating the size of the market, we took into account the impact of COVID-19 and other global crisis.

The global Mirtazapine Drug market is the professional and accurate study of various business perspectives such as major key players, key geographies, divers, restraints, opportunities, and challenges. This global research report has been aggregated on the basis of various market segments and sub-segments associated with the global market.

Top Key Players include in the Mirtazapine Drug Market are
Merck & Co, Sandoz, Teva, Mylan, Sun Pharmaceutical, IMPAX, Aurobindo Pharma, Zydus Pharmaceuticals, APOTEX, and others.

The Mirtazapine Drug market research report is categorized based on type, applications and region.

On the Basis of Type:

• 15mg Tablet
• 30mg Tablet
• 45mg Tablet

On the Basis of Application:

• Hospital
• Drug store

On the Basis of Region:

Geographically, the global Mirtazapine Drug market has been analyzed in various regions such as North America, Latin America, Middle East, Asia-Pacific, Africa, Europe, and India. The global Mirtazapine Drug region is dominating this market in the upcoming future.

North America dominates the mirtazapine drug market owing to the presence of major players, continuous technological development, developed healthcare sector, increasing prevalence of diseases, and rising health awareness in the region. The global mirtazapine drug market in Asia Pacific and Europe is expected to grow over the forecast period owing to increasing research and development activities, increasing investments in the healthcare industry, increasing demand for treatment, and rising patient population.

Further the regions are divided into countries as follows

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
• Germany
• France
• Italy
• Spain
• UK
• Nordic Countries
• Denmark
• Finland
• Iceland
• Sweden
• Norway
• Benelux Union
• Belgium
• The Netherlands
• Luxembourg
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Australia
• South Korea
• Southeast Asia
• Indonesia
• Thailand
• Malaysia
• Singapore
• Rest of Southeast Asia
• Rest of Asia-Pacific
• The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America

Mirtazapine Drug Market report scope

 

What is the CAGR of the global Mirtazapine Drug market?

The Mirtazapine Drug Market is growing at a CAGR of 5.3% During Forecast Period.

Which region would offer high growth for vendors in the Mirtazapine Drug market?

North America dominates the mirtazapine drug market owing to the presence of major players

Which Is the Most potential market segment?

By Types- 15mg Tablet, 30mg Tablet, 45mg Tablet

By Applications - Hospital, Drug store, Others

Which are the top industry players in the global Mirtazapine Drug market?

Merck & Co, Sandoz, Teva, Mylan, Sun Pharmaceutical, IMPAX, Aurobindo Pharma, Zydus Pharmaceuticals, APOTEX